Arkolith/Insider Trading/SLNO/Form 4

Norrett Kevin

Chief Business OfficerSOLENO THERAPEUTICS INC (SLNO) · full profile →Form 4 · filed May 18, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 18, 2026Disposed to issuer(D)18K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 18, 2026Disposed to issuer(D)64K——0
May 18, 2026Disposed to issuer(D)4K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001819690-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML